Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Thrombin inhibitors from Merck & Co.

Feb. 26, 1997

Phase I study of pentosan polysulfate in cancer patients

Feb. 25, 1997

Centocor seeks expansion of ReoPro indications

Feb. 21, 1997

Fibrinogen antagonists from Glaxo Wellcome

Feb. 21, 1997

New dosage strengths of Coumadin available

Feb. 18, 1997

Ibustrin for diabetic vascular complications

Feb. 18, 1997

Ortho synthesizes inhibitors of serine proteases

Feb. 18, 1997

COR Therapeutics discloses factor Xa inhibitors

Feb. 18, 1997

Comparative study of second-generation t-PA inhibitor and alteplase

Feb. 17, 1997

Anti-factor Xa compounds disclosed by RPR

Feb. 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...